Transgene SA – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 12/31/04 FY 2004 – amended

ended 12/31/04 FY 2004

ended 12/31/03 FY 2003

ended 12/31/02 FY 2002

ended 12/31/01 FY 2001

Prospectuses and Registrations Filter

Suspension of duty to report

Suspension of duty to report

Securities registration termination

Post-effective amendment of registration of ADRs

Ownership Filter

≥5% ownership disclosure by active investor

≥5% ownership disclosure by active investor – amended

News Filter

Transgene: 2005, a Year of Significant Achievements Paving the Way for Further Promising Developments in 2006

Awarded € 1.3 M Grant for Hepatitis C Therapeutic Vaccine Programme

RELEASES POSITIVE PHASE I/II DATA OF TG1042 (Ad-IFNg) AND PLANS FOR a PIVOTAL STUDY IN CUTANEOUS B-Cell LYMPHOMA

Transgene: Clinical Pipeline Update

Transgene and the International Aids Vaccine Initiative (Iavi) Sign Manufacturing Agreement

Proxies

No filings in this category.

Other Filter

Letter from the SEC

Correspondence with the SEC

Correspondence with the SEC

Letter from the SEC